中国药物警戒 ›› 2011, Vol. 8 ›› Issue (3): 139-140.

• 基础及临床研究 • 上一篇    下一篇

奥扎格雷钠治疗急性脑梗死的临床研究

孙著叶   

  1. 山东省日照市中医医院,山东 日照 276800
  • 收稿日期:2015-08-27 修回日期:2015-08-27 出版日期:2011-03-10 发布日期:2015-08-27
  • 作者简介:孙著叶,女,主管药师,临床药学。

The Clinical Study of Sodium Ozagrel in Treating Acute Cerebral Infarction

SUN Zhu-ye   

  1. The Traditional Chinese Medicine Hospital of Rizhao, Shangdon Rizhao 276800, China
  • Received:2015-08-27 Revised:2015-08-27 Online:2011-03-10 Published:2015-08-27

摘要: 目的 观察奥扎格雷钠治疗急性脑梗死患者的疗效及治疗前后血液流变学变化。方法 80例急性脑梗死患者随机分为奥扎格雷钠组和川芎嗪组各40例,均静脉滴注给药。治疗组用氯化钠注射液500mL+奥扎格雷钠80mg,每日1次,对照组低分子右旋糖酐500mL+川芎嗪160mg,每日1次,连续应用14天为一疗程。治疗前后观察血液流变学指标及临床疗效、评价。结果 治疗组明显高于对照组(P <0.01),且能降低全血高切粘度,低切粘度,血浆粘度,红细胞压积、纤维蛋白原等;头颅CT检查显示治疗组病灶较对照组有明显改善(P <0.01)。结论 奥扎格雷钠治疗急性脑梗死能显著改善临床症状,降低血液流变学指标。

关键词: 脑梗死, 奥扎格雷钠, 血液流变学

Abstract: Objective To observe the effect of sodium ozagrel in treating the acute cerebral infarction and the change of hemorheology pre and post treatment. Methods Eighty patients of acute cerebral infarction were divided into two groups averragely at random the treatment group and the control group. The former were given 80mg sodium ozagrel solved in 250mL 0.9% sodium chloride, one time a day. And the latter were given 500mL low molecular Dextran with 160mg ligustrazine one time a day. Both were given the drug by intravenous drop for fourteen days.The index of hemorheology and the evaluation of clinical the rapentic effect were observed. Results The effect of treatment group was more significant than the control group(P<0.01), and the low and high-shear whole blood viscosity, plasma shear viscosity,hematocrit and fibrinogen were lowered down in the treatment group. Cranial CT showded that the infarction area also had an more significant improvement(P<0.01). Conclusion Sodium ozagrel can improve the dinical symptoms in treating the acute cerebral infarction significantly and lower down the index of hemorheology.

Key words: cerebral infarction, sodium ozagrel, hemorheology

中图分类号: